Journal of Personalized Medicine (Aug 2023)

The Possible Role of NLRP3 Inflammasome in Depression and Myocardial Infarction Comorbidity

  • Erensu Baysak,
  • Cagan Yildirim,
  • Nurten Sayar,
  • Mustafa Kemal Sayar,
  • Angelos Halaris,
  • Feyza Aricioglu

DOI
https://doi.org/10.3390/jpm13091295
Journal volume & issue
Vol. 13, no. 9
p. 1295

Abstract

Read online

It is well-established that cardiovascular disease and depression are highly comorbid. This study aimed to assess the possible role of the NOD-like receptor protein 3 (NLRP3) inflammasome pathway and the high-sensitivity C-reactive protein (hsCRP) in patients with incident myocardial infarction in the presence or absence of depression. Sixty-eight consecutive patients with incident ST-elevation myocardial infarction and twenty healthy subjects were included. The patients were assessed using the Structured Clinical Interview for DSM-5 Disorders—Clinician Version during their 1–4-day-long hospitalization and were divided into two groups: with and without comorbid depression. Blood samples for the determination of NLRP3, interleukin-18 (IL-18), interleukin-1β (IL-1β), and hsCRP levels were analyzed using ELISA. NLRP3, IL-1β, IL-18, and hsCRP levels were significantly higher in myocardial infarction patients compared to the healthy group (p = 0.02, p p p p = 0.015, OR = 1.72, and CI = 1.11–2.66). The likelihood of depression is associated with increasing NLRP3 levels in myocardial infarction patients. However, this potential role should be further explored in a larger sample.

Keywords